Please sign in to follow a disease.
Nivolumab
Clinical trials for Nivolumab explained in plain language.
Never miss a new study
Get alerted when new Nivolumab trials appear
Sign up with your email to follow new studies for Nivolumab, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail of drugs tested for Tough-to-Treat colon cancer
Disease control PausedThis phase 2 trial is testing whether a combination of four drugs—BMS-986340, nivolumab, trifluridine/tipiracil, and bevacizumab—can help control advanced colorectal cancer that has not responded to standard treatments. The study is for people with a specific type called microsat…
Matched conditions: NIVOLUMAB
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 27, 2026 00:00 UTC
-
Can radiation plus two immunotherapies shrink Hard-to-Treat tumors?
Disease control OngoingThis early-stage trial is testing whether combining targeted radiation (SBRT) with two immunotherapy drugs—nivolumab and an experimental anti-IL-8 antibody—is safe and potentially effective for people with advanced solid tumors or melanoma that have stopped responding to standard…
Matched conditions: NIVOLUMAB
Phase 1 • Sponsor: Yana Najjar • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC